Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 1, 2000

View Archived Issues

Italian Firm Novuspharma Seeks EUR177.3M In Combined Offering

Amrad Cutting Back Operations To Focus On Research Portfolio

European Scientists To Convene On Use Of Genomic Information

Fallout From Cantab Setback Continues With CEO Departure

European Commission Prepares Criteria For GMM Contained Use

Astex Signs Deal With Janssen, Plans Second Funding Round

CAT, HGS Extend Collaboration To Develop Antibodies For BLyS

Industry Seeks Change Of Focus From National To European Level

Jump In Genset's Quarterly Loss Linked To New Corporate Strategy

Medarex Increases IDM Stake Through Licensing Agreement

Uroghne Enters Research Deal, Closes Its First Funding Round

MediGene and Schering Move Cancer Vaccine Into Phase I/II

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
Other news to note for July 20, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Cellution, Dimerix, Elutia, IPG, Jasper, Kira, Lumibird, Medtronic,...